Your browser doesn't support javascript.
loading
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma.
Rechberger, Julian S; Porath, Kendra A; Zhang, Liang; Nesvick, Cody L; Schrecengost, Randy S; Sarkaria, Jann N; Daniels, David J.
Afiliação
  • Rechberger JS; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Porath KA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA.
  • Zhang L; Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Nesvick CL; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Schrecengost RS; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Sarkaria JN; Targepeutics, Inc., Hershey, PA 17033, USA.
  • Daniels DJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Pharmaceutics ; 14(5)2022 Apr 24.
Article em En | MEDLINE | ID: mdl-35631512
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article